Active Wrathful Watching Stock: JPMorgan Chase (NYSE:JPM), Huntington Bancshares (NASDAQ:HBAN)

JPMorgan Chase & Co. (NYSE:JPM) [Trend Analysis] moved up reacts as active mover, shares an advance 1.21% to traded at $84.72 and the percentage gap between open changing to regular change was 0.25%. J.P. Morgan’s Corporate & Investment Bank reported that it has been selected by BlackRock, a global leader in investment management, to provide custody and fund services for over $1 trillion of its clients’ assets. The landmark transaction is among the largest custody deals ever signed. J.P. Morgan expects to onboard the assets over the next two years.

In addition to important new mandates, such as the deal with BlackRock, the bank has surged business with existing custody clients by 10% over the last 12 months. Overall, the bank serves approximately 2,500 custody clients in more than 100 markets, providing settlement, safekeeping and asset servicing of securities along with accounting and administration services for funds. The firm past twelve months price to sales ratio was 5.41 and price to cash ratio remained 0.28. As far as the returns are concern, the return on equity was recorded as 10.00% and return on investment was 5.90% while its return on asset stayed at 0.90%. The firm has total debt to equity ratio measured as 1.29.

Huntington Bancshares Incorporated (NASDAQ:HBAN) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it 1.45% to close at $13.25 with the total traded volume of 14.19 Million shares. Huntington Bancshares Inc. (HBAN) declared that its Q4 profit of $212.3 million. The bank, based in Columbus, Ohio, said it had earnings of 18 cents per share. Earnings, adjusted for non-recurring costs, came to 24 cents per share. The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 22 cents per share.

The regional bank holding company posted revenue of $1.15 billion in the period. Its adjusted revenue was $1.07 billion, which also topped Street forecasts. Six analysts surveyed by Zacks expected $1.05 billion. For the year, the company declared profit of $685.1 million, or 67 cents per share. Revenue was declared as $3.56 billion.

The firm has institutional ownership of 71.10%, while insider ownership included 0.40%. Its price to sales ratio ended at 6.04. HBAN attains analyst recommendation of 2.50 with week’s performance of 2.32%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *